Bio-Rad Laboratories, Inc. (BIO) vs DENTSPLY SIRONA Inc. (XRAY)
A side-by-side comparison of Bio-Rad Laboratories, Inc. and DENTSPLY SIRONA Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.
BIO
Bio-Rad Laboratories, Inc.
$337.54HealthcareDelayed quote: Jul 29, 2026, 10:05 AM EDT
XRAY
DENTSPLY SIRONA Inc.
$14.11HealthcareDelayed quote: Jul 29, 2026, 10:05 AM EDT
Total return — BIO vs XRAY
growth of $100 · dividends reinvested · last 30yBIO +2173.0%XRAY +155.6%BIO compounded faster
Log scale — wide-divergence pair
BIO XRAY
BIO vs XRAY: by the numbers
- •BIO is the larger company ($9.13B vs $2.83B market cap).
- •BIO is profitable (6.52% net margin) while XRAY runs a net loss (-17.06%).
- •XRAY grew revenue faster over the past five years (1.12% vs 0.29% CAGR).
- •XRAY pays a dividend (2.37% yield), while BIO has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BIO | XRAY |
|---|---|---|
| P/E ratio | 54.53 | N/A |
| Forward P/E | 36.61 | 9.51 |
| P/S ratio | 3.45 | 0.73 |
| P/B ratio | 1.30 | 2.05 |
| EV / EBITDA | 22.38 | 8.52 |
| FCF yield | 4.00% | 3.86% |
Profitability
| Metric | BIO | XRAY |
|---|---|---|
| Gross margin | 51.87% | 48.93% |
| Operating margin | 9.25% | 5.87% |
| Net margin | 6.52% | -17.06% |
| ROE | 2.46% | -47.65% |
| ROIC | 2.04% | 5.67% |
Dividends
| Metric | BIO | XRAY |
|---|---|---|
| Dividend yield | N/A | 2.37% |
Growth (annualized)
| Metric | BIO | XRAY |
|---|---|---|
| Revenue CAGR (5Y) | 0.29% | 1.12% |
| EPS CAGR (5Y) | -26.27% | -0.93% |
| FCF CAGR (5Y) | -7.57% | -29.96% |
| Total return CAGR (5Y) | -14.06% | -25.46% |
Frequently asked
- Which has grown faster, BIO or XRAY?
- Over the past five years, XRAY grew revenue faster — BIO at a 0.29% CAGR versus XRAY at 1.12%.
- Does BIO or XRAY pay a bigger dividend?
- XRAY pays a dividend (2.37% yield), while BIO has no payments in the available dividend history.
- Is BIO or XRAY more profitable?
- BIO runs the higher net margin — BIO at 6.52% versus XRAY at -17.06%.
- How have BIO and XRAY total returns compared?
- Over the past 10 years, BIO delivered 8.64% and XRAY delivered -13.07% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bio-Rad Laboratories P/E ratioDENTSPLY SIRONA P/E ratioBio-Rad Laboratories dividend yieldDENTSPLY SIRONA dividend yieldBio-Rad Laboratories ROEDENTSPLY SIRONA ROEBio-Rad Laboratories operating marginDENTSPLY SIRONA operating marginBio-Rad Laboratories revenue growthDENTSPLY SIRONA revenue growthBio-Rad Laboratories free cash flowDENTSPLY SIRONA free cash flow
Bio-Rad Laboratories & DENTSPLY SIRONA appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.